Cian Healthcare Limited

CHCL

INE05BN01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 03:30:57 04/07/2024 pm IST			5-day change	1st Jan Change
24.47 ^INR	+2.64%		-1.25%	+43.35%

2023	Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	MT
2023	Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI

Cian Healthcare Limited Announces Resignation of Smita Gujral Khanna the Independent Director

June 02, 2020 at 05:47 pm IST

Cian Healthcare Limited announced that, the Company has received resignation letter from Mrs. Smita Gujral Khanna the Independent Director of the Company due to personal reasons with immediate effect.

Latest news about Cian Healthcare Limited

Cian Healthcare to Supply 13 Pharmaceutical Products for HLL Lifecare	06/12	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2023	14/11	CI
Cian Healthcare to Export Products to Guatemala Via New Deal	11/23/11	MT
Cian Healthcare Limited Enters into Merchant Export Agreement with Tamil Pharma Pvt Ltd	11/23/11	CI
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2023	05/23/05	CI
Cian Healthcare Signs Deal to Manufacture Products for Nigerian Pharmaceutical Firm	22/23/22	MT
Cian Healthcare Limited Enters into an Agreement with CHI Pharmaceuticals Limited	22/23/22	CI
Crisil Lowers Rating on Cian Healthcare's Bank Loans to D; Outlook	20/23/20	MT
Crisil Gives B+ Rating to Cian Healthcare's Bank Loans; Outlook Stable	02/23/02	MT
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2022	14/22/14	CI
Cian Healthcare Limited Announces Resignation of Santosh Pimparkar as Wholetime Director	08/22/08	CI
Cian Healthcare Gets Board's Approval to Move Shares to BSE's Main Board	26/22/26	MT
Cian Healthcare Limited Reports Earnings Results for the Full Year Ended March 31, 2022	05/22/05	CI
Cian Healthcare Limited Appoints Paresh Arun Shah as Additional Director, Date of Appointment Is 25 August, 2022	26/22/26	CI
Cian Healthcare Limited Announces Resignation of Damodarkumar Sharma as Wholetime Director	12/22/12	CI
4,900,000 Equity Shares of Cian Healthcare Limited are subject to a Lock-Up Agreement Ending on 30-MAY-2022.	30/22/30	CI
Cian Healthcare Limited Announces Resignation of Mohammad Raees Sheikh as Non-Executive Independent Director	31/22/31	CI
Cian Healthcare Limited Announces Resignation of Shikha Rai as Independent Non-Executive Director	25/22/25	CI
Cian Healthcare Limited Announce Change in Corporate Office	23/21/23	CI
Cian Healthcare Limited Reports Earnings Results for the Half Year Ended September 30, 2021	19/21/19	CI
Cian Healthcare Widens Consolidated Net Loss in Fiscal H1	18/21/18	MT
Cian Healthcare Limited Announces Board Changes	13/21/13	CI
Cian Healthcare Limited announced a financing transaction	12/21/12	CI
Cian Healthcare Limited Announces the Resignation of Dhiraj Shantilal Ostwal as Non-Executive Additional Director of the Company	04/21/04	CI
Cian Healthcare Limited Reports Standalone Earnings Results for the Year Ended March 31, 2021	07/21/07	CI

Chart Cian Healthcare Limited

Duration

Period

More charts

Company Profile

Cian Healthcare Limited is an India-based company, which is engaged in the manufacturing and marketing of pharmaceutical products. The Company is engaged in manufacturing of multiple lines-tablets, capsules, soft gels, liquid orals, ointments/ creams and sachets, cosmetics. The Company operates in five sectors, such as Export, Government Supplies, Merchant Export, Own Brand Franchise Business and Third Party/ Contract manufacturing. Its portfolio comprises gynecology, haematinic, cardio- diabetic, orthopedic, pediatric, derma-cosmetic, and antibiotic, CNS, vitamin and nutrient products. The Company also exports its product to various countries, such as Afghanistan, Benin, Bhutan, Bolivia, Cambodia, Sri Lanka, Myanmar and also enhances its production capacity by installing additional machinery for manufacturing a variety of products. It is also engaged in the business of manufacturing cosmetic products. The Company's subsidiary includes Dr. Smith Biotech Private Limited.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
CIAN HEALTHCARE LIMITED	+43.35%	7.14M
ELI LILLY AND COMPANY	+54.07%	809B
NOVO NORDISK A/S	+38.95%	621B
JOHNSON & JOHNSON	-7.05%	351B
MERCK & CO., INC.	+15.44%	319B
ABBVIE INC.	+5.72%	289B
ASTRAZENECA PLC	+14.21%	238B
ROCHE HOLDING AG	-0.45%	221B
NOVARTIS AG	+14.58%	218B
AMGEN INC.	+7.42%	166B